Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesImatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
Journal of Neuro-Oncology, 08/21/09
Dresemann G et al. – No clinically meaningful differences were found between the two treatment arms, and the primary study end point was not met. Among the patients receiving imatinib, no adverse events were reported that were either previously unknown or unexpected as a consequence of the disease.
Related Articles
Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme
Journal of Neuro-Oncology, 10/28/09
Relevance Score: 88%
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Clinical Cancer Research, 10/01/09
Relevance Score: 88%
Multiple extracranial metastases from secondary glioblastoma multiforme: a case report and review of the literature
Journal of Neuro-Oncology, 11/18/09
Relevance Score: 87%
Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
Clinical Cancer Research, 10/06/09
Relevance Score: 87%
Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme
Journal of Neuro-Oncology, 10/01/09
Relevance Score: 87%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Cancer Research, 12/11/09
Glioblastoma Proto-oncogene SEC61gamma Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress
Cancer Research, 12/11/09
Time Trends in Brain Tumor Incidence Rates in Denmark, Finland, Norway, and Sweden, 1974–2003
Journal of the National Cancer Institute, 12/10/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiation Therapy for Rectal Cancer: Current Status and Future Directions
Cancer Control, 12/11/09
Current Progress in Targeted Therapy for Colorectal Cancer
Cancer Control, 12/11/09
Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study
British Journal of Haematology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor